{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-029537","form_type":"8-K","ticker":null,"cik":"0000764195","company_name":"VBI Vaccines Inc/BC","filed_at":"2024-07-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.808572+00:00","generated_at":"2026-05-31T15:31:27.903875+00:00","sec_items":["1.03","2.03","2.04","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"VBI Vaccines files for CCAA creditor protection; DIP loan of $2.5M at 17.5%","bullets":["Ontario Superior Court granted CCAA protection on July 29, 2024; Ernst & Young appointed monitor.","K2 HealthVentures provides up to $2.5M DIP facility at 17.5% interest to fund operations during proceedings.","VBI will seek Chapter 15 in US and Israeli insolvency protection; SISP for asset sale expected.","Company notified Nasdaq of expected delisting and cessation of public reporting.","Restructuring triggers default under existing Loan Agreement; obligations accelerated with 5% default interest increase."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-029537","json":"https://secwatch.observer/filing/0001493152-24-029537.json","markdown":"https://secwatch.observer/filing/0001493152-24-029537.md","text":"https://secwatch.observer/filing/0001493152-24-029537.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/764195/000149315224029537/0001493152-24-029537-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/764195/000149315224029537/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T15:31:27.903875+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"31483b79b6daaa18683b8d42632894c5436abb60","claim":"VBI Vaccines Inc/BC entered chapter 15 in U.S. Bankruptcy Court for the District of Delaware (petition 2024-07-29).","evidence_excerpt":"the Company and certain of its subsidiaries intend to commence a case under Chapter 15 of the United States Bankruptcy Code (the “ Bankruptcy Code ”) under the jurisdiction of the U.S. Bankruptcy Court for the District of Delaware","evidence_source":"SEC 8-K Item 1.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/764195/000149315224029537/0001493152-24-029537-index.htm","confidence":0.9,"family_label":"Distress & Bankruptcy","details":[{"label":"Proceeding","value":"chapter 15"},{"label":"Court","value":"U.S. Bankruptcy Court for the District of Delaware"},{"label":"Petition","value":"2024-07-29"}],"fact_type":"distress_event"},{"claim_id":"b0ce37449aabc07854a47b993a04196fea2ef1c9","claim":"VBI Vaccines Inc/BC entered chapter 11 in Ontario Superior Court of Justice (Commercial List) (petition 2024-07-29).","evidence_excerpt":"On July 29, 2024, after considering all strategic alternatives following consultation with its legal and financial advisors, VBI Vaccines Inc. (the “ Company ”) and its subsidiaries commenced voluntary restructuring under the jurisdiction of the Ontario Superior Court of Justice (Commercial List) pursuant to the Companies’ Creditors Arrangement Act","evidence_source":"SEC 8-K Item 1.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/764195/000149315224029537/0001493152-24-029537-index.htm","confidence":0.9,"family_label":"Distress & Bankruptcy","details":[{"label":"Proceeding","value":"chapter 11"},{"label":"Court","value":"Ontario Superior Court of Justice (Commercial List)"},{"label":"Petition","value":"2024-07-29"}],"fact_type":"distress_event"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}